SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 6.965+15.3%Feb 9 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: luckydog88 who wrote (1391)1/29/2026 11:59:48 AM
From: waitwatchwander2 Recommendations

Recommended By
erippetoe
Olecranon

  Read Replies (1) of 1402
 
It's interesting that the drug talked about in that StatNews article is a chemo drug with a novel delivery system which is nothing like Anktiva and it's effect on one's immune system.

share.google (scroll up for a summary of the StatNews article)

Peculiar that the StatNews writer doesn't state that BCG has been used as a bladder cancer treatment for almost half a century, although only approved by FDA in the 1990's.

share.google
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News